SCHEMBL20363256

SCHEMBL20363256

CCCCCC(C)(CCCC)C(=O)NCc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.59
EPHX2 P34913 4/20 0.56
MMP8 P22894 2/20 0.50
FAAH O00519 2/20 0.49
POLB P06746 1/20 0.48
OPRK1 P41145 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
CNR1 P21554 1/20 0.47
CNR2 P34972 1/20 0.47
GAA P10253 2/20 0.46
LMNA P02545 1/20 0.46
RAB9A P51151 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C19 P33261 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CTSK P43235 1/20 0.44
HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20363329 0.97 RIPK1 (0.62) RIPK1EPHX2MMP8FAAHPOLB
SCHEMBL20363306 0.86 HPGD (0.57) RIPK1EPHX2FAAHLMNARAB9A
SCHEMBL20363286 0.86 ALDH1A1 (0.57) POLBSMN1; SMN2CNR1CNR2GAA
SCHEMBL20363229 0.86 RAB9A (0.50) RIPK1POLBSMN1; SMN2GAALMNA
SCHEMBL28477588 0.85 RIPK1 (0.68) RIPK1EPHX2MMP8FAAHPOLB
SCHEMBL20363294 0.85 RAB9A (0.49) EPHX2POLBSMN1; SMN2LMNARAB9A
SCHEMBL20363296 0.84 RAB9A (0.51) RIPK1POLBSMN1; SMN2GAALMNA
Hydrochloric Acid SCHEMBL26667075 0.84 RIPK1 (0.66) RIPK1EPHX2MMP8FAAHPOLB
SCHEMBL20363333 0.84 ALDH1A1 (0.58) RIPK1POLBSMN1; SMN2CNR1CNR2
SCHEMBL20363262 0.84 HPGD (0.48) RIPK1SMN1; SMN2LMNARAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10017522-B2 Alpha helix mimetics and methods relating thereto Prism BioLab Co., Ltd. (JP) 2018-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10017522-B2 Alpha helix mimetics and methods relating thereto PLOD3, COL1A1, THPO RIPK1 4263/4885EPHX2 316/4885MMP8 849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.